Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance

Mahesh Bachu, Swarupa Yalla, Mangaiarkarasi Asokan, Anjali Verma, Ujjwal Neogi, Shilpee Sharma, Rajesh V. Murali, Anil Babu Mukthey, Raghavendra Bhatt, Snehajyoti Chatterjee, Roshan Elizabeth Rajan, Narayana Cheedarla, Venkat S. Yadavalli, Anita Mahadevan, Susarla K. Shankar, Nirmala Rajagopalan, Anita Shet, Shanmugam Saravanan, Pachamuthu Balakrishnan, Suniti SolomonMadhu Vajpayee, Kadappa Shivappa Satish, Tapas K. Kundu, Kuan Teh Jeang, Udaykumar Ranga

Research output: Contribution to journalArticle

Abstract

We demonstrate that at least three different promoter variant strains of HIV-1 subtype C have been gradually expanding and replacing the standard subtype C viruses in India, and possibly in South Africa and other global regions, over the past decade. The new viral strains contain an additional NF-κB, NF-κB-like, or RBEIII site in the viral promoter. Although the acquisition of an additional RBEIII site is a property shared by all the HIV-1 subtypes, acquiring an additional NF-κB site remains an exclusive property of subtype C. The acquired κB site is genetically distinct, binds the p50-p65 heterodimer, and strengthens the viral promoter at the levels of transcription initiation and elongation. The 4-κB viruses dominate the 3-κB "isogenic" viral strains in pairwise competition assays in T-cell lines, primary cells, and the ecotropic human immunodeficiency virus mouse model. The dominance of the 4-κB viral strains is also evident in the natural context when the subjects are coinfected with κB-variant viral strains. The mean plasma viral loads, but not CD4 counts, are significantly different in 4-κB infection suggesting that these newly emerging strains are probably more infectious. It is possible that higher plasma viral loads underlie selective transmission of the 4-κB viral strains. Several publications previously reported duplication or deletion of diverse transcription factor-binding sites in the viral promoter. Unlike previous reports, our study provides experimental evidence that the new viral strains gained a potential selective advantage as a consequence of the acquired transcription factor-binding sites and importantly that these strains have been expanding at the population level.

Original languageEnglish (US)
Pages (from-to)44714-44735
Number of pages22
JournalJournal of Biological Chemistry
Volume287
Issue number53
DOIs
StatePublished - Dec 28 2012
Externally publishedYes

Fingerprint

Terminal Repeat Sequences
Transcription
Viral Load
HIV-1
Transcription Factors
Binding Sites
Cercopithecine Herpesvirus 1
CD4 Lymphocyte Count
South Africa
Publications
India
HIV
Viruses
T-Lymphocytes
Cell Line
Infection
Population
Plasmas
T-cells
Elongation

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. / Bachu, Mahesh; Yalla, Swarupa; Asokan, Mangaiarkarasi; Verma, Anjali; Neogi, Ujjwal; Sharma, Shilpee; Murali, Rajesh V.; Mukthey, Anil Babu; Bhatt, Raghavendra; Chatterjee, Snehajyoti; Rajan, Roshan Elizabeth; Cheedarla, Narayana; Yadavalli, Venkat S.; Mahadevan, Anita; Shankar, Susarla K.; Rajagopalan, Nirmala; Shet, Anita; Saravanan, Shanmugam; Balakrishnan, Pachamuthu; Solomon, Suniti; Vajpayee, Madhu; Satish, Kadappa Shivappa; Kundu, Tapas K.; Jeang, Kuan Teh; Ranga, Udaykumar.

In: Journal of Biological Chemistry, Vol. 287, No. 53, 28.12.2012, p. 44714-44735.

Research output: Contribution to journalArticle

Bachu, M, Yalla, S, Asokan, M, Verma, A, Neogi, U, Sharma, S, Murali, RV, Mukthey, AB, Bhatt, R, Chatterjee, S, Rajan, RE, Cheedarla, N, Yadavalli, VS, Mahadevan, A, Shankar, SK, Rajagopalan, N, Shet, A, Saravanan, S, Balakrishnan, P, Solomon, S, Vajpayee, M, Satish, KS, Kundu, TK, Jeang, KT & Ranga, U 2012, 'Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance', Journal of Biological Chemistry, vol. 287, no. 53, pp. 44714-44735. https://doi.org/10.1074/jbc.M112.397158
Bachu, Mahesh ; Yalla, Swarupa ; Asokan, Mangaiarkarasi ; Verma, Anjali ; Neogi, Ujjwal ; Sharma, Shilpee ; Murali, Rajesh V. ; Mukthey, Anil Babu ; Bhatt, Raghavendra ; Chatterjee, Snehajyoti ; Rajan, Roshan Elizabeth ; Cheedarla, Narayana ; Yadavalli, Venkat S. ; Mahadevan, Anita ; Shankar, Susarla K. ; Rajagopalan, Nirmala ; Shet, Anita ; Saravanan, Shanmugam ; Balakrishnan, Pachamuthu ; Solomon, Suniti ; Vajpayee, Madhu ; Satish, Kadappa Shivappa ; Kundu, Tapas K. ; Jeang, Kuan Teh ; Ranga, Udaykumar. / Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. In: Journal of Biological Chemistry. 2012 ; Vol. 287, No. 53. pp. 44714-44735.
@article{853cdf26e2534eed93647d2c5f3fc935,
title = "Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance",
abstract = "We demonstrate that at least three different promoter variant strains of HIV-1 subtype C have been gradually expanding and replacing the standard subtype C viruses in India, and possibly in South Africa and other global regions, over the past decade. The new viral strains contain an additional NF-κB, NF-κB-like, or RBEIII site in the viral promoter. Although the acquisition of an additional RBEIII site is a property shared by all the HIV-1 subtypes, acquiring an additional NF-κB site remains an exclusive property of subtype C. The acquired κB site is genetically distinct, binds the p50-p65 heterodimer, and strengthens the viral promoter at the levels of transcription initiation and elongation. The 4-κB viruses dominate the 3-κB {"}isogenic{"} viral strains in pairwise competition assays in T-cell lines, primary cells, and the ecotropic human immunodeficiency virus mouse model. The dominance of the 4-κB viral strains is also evident in the natural context when the subjects are coinfected with κB-variant viral strains. The mean plasma viral loads, but not CD4 counts, are significantly different in 4-κB infection suggesting that these newly emerging strains are probably more infectious. It is possible that higher plasma viral loads underlie selective transmission of the 4-κB viral strains. Several publications previously reported duplication or deletion of diverse transcription factor-binding sites in the viral promoter. Unlike previous reports, our study provides experimental evidence that the new viral strains gained a potential selective advantage as a consequence of the acquired transcription factor-binding sites and importantly that these strains have been expanding at the population level.",
author = "Mahesh Bachu and Swarupa Yalla and Mangaiarkarasi Asokan and Anjali Verma and Ujjwal Neogi and Shilpee Sharma and Murali, {Rajesh V.} and Mukthey, {Anil Babu} and Raghavendra Bhatt and Snehajyoti Chatterjee and Rajan, {Roshan Elizabeth} and Narayana Cheedarla and Yadavalli, {Venkat S.} and Anita Mahadevan and Shankar, {Susarla K.} and Nirmala Rajagopalan and Anita Shet and Shanmugam Saravanan and Pachamuthu Balakrishnan and Suniti Solomon and Madhu Vajpayee and Satish, {Kadappa Shivappa} and Kundu, {Tapas K.} and Jeang, {Kuan Teh} and Udaykumar Ranga",
year = "2012",
month = "12",
day = "28",
doi = "10.1074/jbc.M112.397158",
language = "English (US)",
volume = "287",
pages = "44714--44735",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "53",

}

TY - JOUR

T1 - Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance

AU - Bachu, Mahesh

AU - Yalla, Swarupa

AU - Asokan, Mangaiarkarasi

AU - Verma, Anjali

AU - Neogi, Ujjwal

AU - Sharma, Shilpee

AU - Murali, Rajesh V.

AU - Mukthey, Anil Babu

AU - Bhatt, Raghavendra

AU - Chatterjee, Snehajyoti

AU - Rajan, Roshan Elizabeth

AU - Cheedarla, Narayana

AU - Yadavalli, Venkat S.

AU - Mahadevan, Anita

AU - Shankar, Susarla K.

AU - Rajagopalan, Nirmala

AU - Shet, Anita

AU - Saravanan, Shanmugam

AU - Balakrishnan, Pachamuthu

AU - Solomon, Suniti

AU - Vajpayee, Madhu

AU - Satish, Kadappa Shivappa

AU - Kundu, Tapas K.

AU - Jeang, Kuan Teh

AU - Ranga, Udaykumar

PY - 2012/12/28

Y1 - 2012/12/28

N2 - We demonstrate that at least three different promoter variant strains of HIV-1 subtype C have been gradually expanding and replacing the standard subtype C viruses in India, and possibly in South Africa and other global regions, over the past decade. The new viral strains contain an additional NF-κB, NF-κB-like, or RBEIII site in the viral promoter. Although the acquisition of an additional RBEIII site is a property shared by all the HIV-1 subtypes, acquiring an additional NF-κB site remains an exclusive property of subtype C. The acquired κB site is genetically distinct, binds the p50-p65 heterodimer, and strengthens the viral promoter at the levels of transcription initiation and elongation. The 4-κB viruses dominate the 3-κB "isogenic" viral strains in pairwise competition assays in T-cell lines, primary cells, and the ecotropic human immunodeficiency virus mouse model. The dominance of the 4-κB viral strains is also evident in the natural context when the subjects are coinfected with κB-variant viral strains. The mean plasma viral loads, but not CD4 counts, are significantly different in 4-κB infection suggesting that these newly emerging strains are probably more infectious. It is possible that higher plasma viral loads underlie selective transmission of the 4-κB viral strains. Several publications previously reported duplication or deletion of diverse transcription factor-binding sites in the viral promoter. Unlike previous reports, our study provides experimental evidence that the new viral strains gained a potential selective advantage as a consequence of the acquired transcription factor-binding sites and importantly that these strains have been expanding at the population level.

AB - We demonstrate that at least three different promoter variant strains of HIV-1 subtype C have been gradually expanding and replacing the standard subtype C viruses in India, and possibly in South Africa and other global regions, over the past decade. The new viral strains contain an additional NF-κB, NF-κB-like, or RBEIII site in the viral promoter. Although the acquisition of an additional RBEIII site is a property shared by all the HIV-1 subtypes, acquiring an additional NF-κB site remains an exclusive property of subtype C. The acquired κB site is genetically distinct, binds the p50-p65 heterodimer, and strengthens the viral promoter at the levels of transcription initiation and elongation. The 4-κB viruses dominate the 3-κB "isogenic" viral strains in pairwise competition assays in T-cell lines, primary cells, and the ecotropic human immunodeficiency virus mouse model. The dominance of the 4-κB viral strains is also evident in the natural context when the subjects are coinfected with κB-variant viral strains. The mean plasma viral loads, but not CD4 counts, are significantly different in 4-κB infection suggesting that these newly emerging strains are probably more infectious. It is possible that higher plasma viral loads underlie selective transmission of the 4-κB viral strains. Several publications previously reported duplication or deletion of diverse transcription factor-binding sites in the viral promoter. Unlike previous reports, our study provides experimental evidence that the new viral strains gained a potential selective advantage as a consequence of the acquired transcription factor-binding sites and importantly that these strains have been expanding at the population level.

UR - http://www.scopus.com/inward/record.url?scp=84871772179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871772179&partnerID=8YFLogxK

U2 - 10.1074/jbc.M112.397158

DO - 10.1074/jbc.M112.397158

M3 - Article

C2 - 23132857

AN - SCOPUS:84871772179

VL - 287

SP - 44714

EP - 44735

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 53

ER -